What Sonio does

Sonio is a Paris-based, AI-powered SaaS company founded in April 2020 that standardizes and automates fetal ultrasound workflows for obstetricians, maternal-fetal medicine (MFM) specialists, sonographers, and women's health organizations. Its cloud-native platform combines reporting, image management, DICOM worklist handling, HL7/FHIR-based EMR and billing integration, PACS/VNA connectivity, visual exam checklists, and practice analytics, sold under a vendor-agnostic model compatible with all ultrasound manufacturers. The company's AI layer includes Sonio Detect (FDA 510(k)-cleared view and anatomical structure detection, now in version 3), Sonio Suspect (FDA 510(k)-cleared anomaly detection across heart, brain, and abdomen), and Sonio Voice (real-time AI-driven voice transcription of ultrasound findings). Sonio has secured five FDA 510(k) clearances, ISO 13485 certification, CE marking, SOC 2 Type 2, HIPAA, and HDS compliance, and was acquired by Samsung Medison in September 2024 while continuing to operate independently and sell across all ultrasound OEMs.

The company monetizes primarily through enterprise SaaS subscriptions sold via direct field sales, with custom quote-based pricing tied to facility size and AI module requirements. Customer segments span OB-GYN and MFM practices, women's health MSOs, academic medical centers, community medical centers, and SMB midwife-sonographer users. Named customers include Pediatrix Medical Group (first US customer, Jan 2024), HCA Healthcare, Genesis, GW MFM, Calla Perinatal, WHASN, TLC Perinatal, DPA, and NJPA, with deployment in over 100 US clinics within two years of first US signing. Distribution in international markets is enabled through channel partners in India (MFine/Lifecell), Brazil (Manager Systems), Nigeria (Dynamic Medical Engineering), and Portugal (Astrimed), alongside an OEM embedding channel opened by the June 2026 Sonio Suspect Integration Configuration FDA clearance. As of the latest data, Sonio operates with 59 employees across Paris, New York, and Cambridge, MA, with the CEO relocated to Boston and a dedicated US Director of Operations.

Name

Sonio

Legal name

Sonio SAS

Website

https://sonio.ai

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

51–100 employees

Short description

Sonio is a Paris-based AI SaaS company, acquired by Samsung Medison in 2024, that provides a cloud-native fetal ultrasound reporting and image-management platform with FDA-cleared AI modules for view detection and anomaly detection, serving OB-GYN and maternal-fetal medicine practices across 100+ US clinics and international channel-partner markets.

Ownership category

akta.pro rank

Product category

Healthcare AI Software - Fetal Ultrasound Reporting and Imaging

NAICS

Medical Laboratories (621511), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)

SIC

Surgical & Medical Instruments & Apparatus (3841), Services-Prepackaged Software (7372)

akta.pro primary industry

SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG)

akta.pro secondary industry

Medical Imaging AI (HDAAAEAH)

Keywords

• Fetal ultrasound software
• Prenatal imaging AI
• OB-GYN reporting software
• Medical imaging AI
• Cloud healthcare platform

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. SaaS Subscriptions - Sonio Platform: Cloud-based subscription software for OB-GYN ultrasound reporting and image management. Pricing based on facility/practice level with tiered plans. Revenue generated from annual or multi-year subscriptions.
2. Sonio Detect (AI Medical Device): FDA 510(k) cleared AI software module. Sold as part of platform subscription or potentially as separate module. Revenue recognized as part of overall SaaS platform.
3. Sonio Suspect (AI Anomaly Detection): FDA 510(k) cleared AI module for anomaly detection. Integrated into Sonio platform, generating revenue through platform subscription model.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Core offering

Sonio develops a cloud-native AI-powered SaaS platform that standardizes and automates fetal ultrasound workflows, from image acquisition and reporting to quality review and billing handoff. The offering combines FDA 510(k) cleared AI modules (Sonio Detect for view/structure detection and quality control, Sonio Suspect for anomaly detection, Sonio Voice for real-time voice transcription) with an OB/GYN reporting SaaS (Sonio Pro) integrated via HL7, FHIR, and DICOM into existing EMR, PACS, and billing systems at OB-GYN and Maternal-Fetal Medicine practices.

Product overview

Sonio offers a cloud-native AI-powered prenatal ultrasound platform with two main product tiers: Sonio Pro (core reporting and workflow SaaS) and add-on AI modules Sonio Detect (quality assurance, view/structure detection) and Sonio Suspect (anomaly detection), all integrated within the unified Sonio Platform. Sonio Voice adds AI-powered voice-driven data input. The architecture is machine-agnostic and interoperable, supporting all ultrasound manufacturers and integrating with EMR, PACS, and billing systems via HL7, FHIR, and DICOM.

Differentiator

Problem solved

Functional benefit

Brands

• Sonio Detect: FDA 510(k) cleared AI product that empowers ultrasound practitioners to perform routine fetal ultrasound examinations with automatic view detection, anatomical structure detection, and quality criteria verification.
• Sonio Pro
• Sonio Suspect
• Sonio Voice
• soniopedia

Products and services

• Sonio Platform Secure, cloud-native AI-powered platform that standardizes and automates fetal ultrasound workflows from image acquisition and reporting to quality review and billing handoff. Integrates with all ultrasound manufacturers and supports HL7, FHIR, and DICOM interoperability for OB-GYN and Maternal-Fetal Medicine practices.
• Sonio Pro SaaS solution for OB/GYN exams that receives and uploads media from ultrasound equipment in DICOM format, acts as a modality worklist for ultrasound equipment, and interacts with EMR and billing systems through HL7. Includes report templates, image management, visual checklist, sharing, and practice analytics modules.
• Sonio Detect FDA 510(k) cleared and CE-marked AI module that empowers ultrasound practitioners to perform fetal ultrasound examinations in real time by automatically detecting views, identifying anatomical structures (brain, thorax, heart, placenta), and verifying image quality criteria against standardized protocols.
• Sonio Suspect FDA 510(k) cleared AI module for prenatal screening with automatic detection of eight abnormal findings across seven ultrasound views of three fetal anatomical regions (heart, brain, abdomen). Demonstrated a 22-point improvement in reader performance (69% to 91% AUC) across 47 sites in a multicenter reader study.
• Sonio Voice AI-powered voice solution integrated with Sonio's ultrasound reporting software that transcribes, interprets, and inputs ultrasound data in real time as sonographers perform exams, converting spoken clinical observations into structured report entries to optimize workflow and reduce administrative burden.
• soniopedia Educational bioinformatic tool for prenatal diagnosis experts that enables users to identify syndromes based on initial ultrasound phenotypes through interactive prenatal diagnosis quizzes. Launched at FMF World Congress 2024 in Lisbon, Portugal.

Quantifiable outcome

• 22-point improvement in anomaly detection performance (69% to 91% AUC) demonstrated in multicenter reader study across 47 sites
• +6 more outcomes

Named customers12 records

Segments8 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability7 records

Feature6 records

Partnerships

Nine partnerships are on record, tiered flagship, core and regional.

• Samsung MedisonflagshipStrategic or Co-development Partner · 2 September 2024Acquisition by Samsung Medison in September 2024 following approval by French Ministry of Economy and Finance. Strategic move to accelerate global growth in maternal care and combine Sonio's AI-driven solutions with Samsung's engineering expertise. Sonio continues commercial operations independently while developing products compatible with all ultrasound manufacturers. Deal enables expansion of ultrasound technology portfolio including next-generation AI products.
• Necker-Enfants Malades University HospitalcoreStrategic or Co-development PartnerLong-standing collaboration with world-renowned children's hospital in Paris, founded in 1802. Multiple Sonio co-founders are affiliated with Necker. Partnership provides clinical validation, research collaboration, and medical expertise for product development.
• MFine (Lifecell)regionalChannel Partner/ Reseller/ DistributorDistribution partnership announced March 2023 to expand Sonio's AI-powered technology in India, a market experiencing increasing demand for advanced medical solutions. MFine is a digital health platform serving millions of patients. Partnership aims to improve accuracy and reliability of pregnancy ultrasound scans in India.
• Manager Systems (Brazil)regionalChannel Partner/ Reseller/ DistributorDistribution partner in Brazil since 1988, focused on delivering quality management of medical services to practitioners and patients across Brazil.
• Dynamic Medical Engineering Company (Nigeria)regionalChannel Partner/ Reseller/ DistributorDistribution partner in Nigeria with mission to improve women's and children's health through technological innovation. General Manager Raymond Okosun runs laboratory for newborn screening, non-invasive prenatal screening, and maternal risk assessments.
• Astrimed (Portugal)regionalChannel Partner/ Reseller/ DistributorDistribution partner in Portugal since 2004, dedicated to delivering products and services of highest quality for health systems. Expertise in marketing and supporting medical software and equipment across hospitals, clinics, and practitioners.
• École PolytechniquecoreTechnology or IntegrationTechnical partnership with globally renowned institution excelling in science, engineering, and research. Pr. Erwan Le Pennec from Applied Mathematics at École Polytechnique serves on Scientific Advisory Board.
• PrairiecoreTechnology or IntegrationResearch institute and innovation center driving AI and machine learning progress. Partnership supports Sonio's AI development capabilities.
• Samsung Healthcare FrancecoreTechnology or IntegrationInitial partnership announced September 2021 joining Samsung Healthcare ecosystem. Confirmed innovative nature of AI solutions dedicated to securing pregnancy monitoring and optimizing prenatal diagnosis. Preceded acquisition by Samsung Medison.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• GE HealthCare: Global leader in ultrasound (Voluson) and AI-powered imaging. Directly competes with Sonio's AI modules through its own ultrasound AI initiatives (including Caption Health acquisition) and has overlapping target customers in OB-GYN and MFM practices.
• Siemens Healthineers: Ultrasound OEM (ACUSON) with AI-augmented imaging capabilities and integrated OB/GYN workflows. Comparable through direct ultrasound hardware sales plus AI features and shared MFM customer base.
• Samsung Medison: Parent company of Sonio since September 2024 and a leading OB-GYN ultrasound OEM (HERA W10). Closest incumbent peer given direct ownership relationship and overlapping product/portfolio strategy.
• Philips: Major ultrasound manufacturer (Philips EPIQ, Affiniti) with growing AI-based obstetrics and radiology tools. Comparable as a full-stack ultrasound + AI/saMD competitor in OB-GYN and MFM markets.

Emerging players

• Ultromics: AI echocardiography platform (FDA-cleared) for cardiac function analysis. Comparable as a focused AI ultrasound SaMD company pursuing specialty diagnostic use cases with regulatory clearances and cloud delivery.
• Caption Health (GE HealthCare): AI guidance software for ultrasound acquisition (initially cardiac, expanding to broader point-of-care). Acquired by GE HealthCare in 2023; directly comparable as AI ultrasound SaaS that helps less experienced users capture diagnostic-quality exams.
• Butterfly Network: Portable, AI-enabled ultrasound platform with cloud-based workflow software. Comparable as a connected ultrasound + AI SaaS play, though more focused on point-of-care than OB-GYN specialty.
• Koios Medical: AI-based clinical decision support for medical imaging (breast, thyroid, prostate) with FDA-cleared SaMD products. Comparable as a specialty AI imaging SaMD vendor with similar go-to-market in clinical practices.

Direct peers

• See-Mode Technologies: AI software for obstetric and vascular ultrasound, including automated detection, measurements, and reporting. Closest direct competitor in AI-driven fetal/obstetric ultrasound workflows and reporting automation.

Regional players

• Mindray: China-based ultrasound OEM with growing global presence and embedded AI capabilities in OB-GYN imaging. Comparable as ultrasound manufacturer competing in MFM/OB-GYN market with bundled AI features.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/sonio
• Facebookfacebook.com/soniohealth
• Xx.com/soniohealth

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds4 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sonio